Skip to main content

Figures of Quantifiable Data in Support of Achieved Goals

  • Chapter
  • First Online:
Perspectives in Translational Research in Life Sciences and Biomedicine

Abstract

Antibodies or immunoglobulin are glycoproteins produced by B-cells and play a central role in host immune defense. The immune response to any given antigen is diverse, comprising different antibodies exhibiting different affinities and/or epitope specificities. The conventional antibodies consist of a heavy (H) chain and a light (L) chain, each containing variable and constant regions. In Camelidae (camels and llamas) apart from the conventional antibodies, additional class of functional antibodies consisting of only heavy chains (HCAbs) is also present . The antigen (Ag)-binding site of these antibodies is composed solely of variable domain (VHH) with a mass of 15000 Da.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. De Genst E, Saerens D, Muyldermans S, Conrath KE. Antibody repertoire development in camelids. Dev Comp Immunol. 2006;30:187–98.

    Article  PubMed  Google Scholar 

  2. Harmsen MM, de Haard H. Properties, production, and applications of camelid single-domain antibody fragments. Appl Microbiol Biotechnol. 2007;77:13–22.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Muyldermans S. Single domain camel antibodies: current status. J Biotechnol. 2001;74:277–302.

    CAS  PubMed  Google Scholar 

  4. Ghahroudi MA, Desmyter A, Wyns L, Hamers R, Muyldermans S. Selection and identification of single domain antibody fragments from camel heavy-chain antibodies. FEBS Lett. 1997;414:521–6.

    Article  Google Scholar 

  5. Coppieters K, Dreier T, Silence K, de Haard H, Lauwereys M, Casteels P, Beirnaert E, Jonckheere H, Van de Wiele C, StaelensL Hostens J, Revets H, RemautE Elewaut D, Rottiers P. Formatted anti-tumor necrosis factor alpha VHH proteins derived from camelids show superior potency and targeting to inflamed joints in a murine model of collagen-induced arthritis. Arthritis Rheum. 2006;54:1856–66.

    Article  CAS  PubMed  Google Scholar 

  6. Baral TN, Magez S, Stijlemans B, Conrath K, Vanhollebeke B, Pays E, Muyldermans S, De Baetselier P. Experimental therapy of African trypanosomiasis with a nanobody-conjugated human trypanolytic factor. Nat Med. 2006;12:580–4.

    Article  CAS  PubMed  Google Scholar 

  7. Muyldermans S, Baral TN, Cortez-Retamozzo V, De Baetselier P, De Genst E, Kinne J, Leonhardt H, Magez S, Nguyen VK, Revets H, Rothbauer U, StijlemansB, Tillib S, Wernery U, Wyns L, Hassanzadeh-GhassabehGh, Saerens D. Camelid immunoglobulins and nanobody technology. Vet Immunol Immunopathol. 2008:1–6.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ena Ray Banerjee .

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer Science+Business Media Singapore

About this chapter

Cite this chapter

Ray Banerjee, E. (2016). Figures of Quantifiable Data in Support of Achieved Goals. In: Perspectives in Translational Research in Life Sciences and Biomedicine. Springer, Singapore. https://doi.org/10.1007/978-981-10-0989-1_12

Download citation

Publish with us

Policies and ethics